GRVE
Groove Botanicals Inc
Q1 2026 Report
Groove Botanicals Inc (GRVE) QQ1 2026 Results: Q1 2026 Earnings Review and Market Implications...
Read full report
Executive Summary
Groove Botanicals Inc reported a nominal operating loss in QQ3 2025, with no disclosed revenue for the quarter. The company posted an operating loss of 33,031 USD and a net loss of 33,031 USD, accompanied by SG&A expenses of 33,031 USD. The company’s cash burn from operations was 25,861 USD, leaving cash and cash equivalents of 1,251 USD at quarter-end. The balance sheet signals acute liquidity stress, with total current liabilities of 1,028,546 USD and total assets of 4,733 USD, producing a current ratio of 0.0046 and a negative stockholders’ equity of -1,023,813 USD. Free cash flow for QQ3 2025 was -25,861 USD, and the company shows a negative earnings per share (EPS) of -0.0015 USD. Management commentary is not provided in the data set; no earnings transcript is available for QQ3 2025, limiting insight into strategic pivots or near-term guidance. Investors should treat this as a high-risk, high-uncertainty report until more granular revenue data, updated guidance, and a credible path to liquidity are disclosed.
Key Performance Indicators
Operating Income
-33.03K
QoQ: -10.72% | YoY:40.16%
Net Income
-33.03K
QoQ: -10.72% | YoY:-236.46%
EPS
0.00
QoQ: -7.14% | YoY:-475.00%
Revenue Trend
Margin Analysis
Key Insights
- Revenue: Not disclosed for QQ3 2025. - Operating income: -33,031 USD; YoY +40.16%, QoQ -10.72% (per provided metrics). - Net income: -33,031 USD; YoY -236.46%, QoQ -10.72%. - EPS: -0.0015 USD; YoY -475%, QoQ -7.14%. - SG&A: 33,031 USD. - CFO: -25,861 USD; Net cash from financing activities: +20,979 USD. - Cash and cash equivalents: 1,251 USD. - Total current liabilities: 1,028,546 USD. - Total assets: 4,733 USD. - Share count: 59,643,062 basic and diluted. - Current ratio: 0.0046; Quick ratio: 0.0046; Cash ratio: 0.00122.